Business · 1 sources covering this

Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes

The U.S. is the company’s largest market for innovative medicines and a cornerstone of its long-term growth strategy, generating approximately 27% of the company’s global revenue.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

The HinduLean L·1h ago
Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes
The U.S. is the company’s largest market for innovative medicines and a cornerstone of its long-term growth strategy, generating approximately 27% of the company’s global revenue.
Read at The Hindu →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/068a65554eb1940857936d3fe2bba56f8c2a1ec4"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes"></iframe>

Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes

How 1 sources are covering this

Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes

More from Business

Maharashtra govt approves policy to eradicate drugs from the state by 2029

Haryana fines Gurugram town planner over failure to answer RTI properly

Tata Elxsi inks pact with Sarla Aviation to make air taxi platform Shunya

Scott Bessent says US likely to announce Iran bank sanctions this week

Reader

Trust & legal

Across the network